Recruiting
Phase 1

Study of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

Sponsor:

Gilead Sciences

Code:

NCT05007782

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Denikitug

Zimberelimab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information